Copyright ©2013 Baishideng.
World J Hematol. May 6, 2013; 2(2): 20-43
Published online May 6, 2013. doi: 10.5315/wjh.v2.i2.20
Figure 9
Figure 9 2005 ECMP concept on the molecular etiology of essential thrombocythemia, prodromal and overt polycythemia vera, leukocythemia, platelet-mediated microvascular thrombosis, increased blood volume and secondary myelofibrosis in JAK2 muated classical myeloproliferative disorders. ET: Essential thrombocythemia; PV: Polycythemia vera; LAP: Leukocyte alkaline phosphatase; MPD: Myeloproliferative disorders; IFN: Interferon. Originated from Michiels et al[106,107].